Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation

US11844878B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11844878-B2
Application numberUS-201916527804-A
CountryUS
Kind codeB2
Filing dateJul 31, 2019
Priority dateSep 6, 2011
Publication dateDec 19, 2023
Grant dateDec 19, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Hydrogels comprising a macromolecular matrix and water may be used to augment soft tissue of a human being, promote or support cell or tissue viability or proliferation, create space in tissue, and for other purposes. A macromolecular matrix may comprise a hyaluronic acid component crosslinked to a collagen component.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of improving fat graft volume retention, the method comprising: (i) providing a hydrogel component, the hydrogel component comprising: (a) water; (b) a crosslinked macromolecular matrix comprising hyaluronic acid crosslinked to collagen via a plurality of crosslink units, wherein the hyaluronic acid is crosslinked with the collagen via a water-soluble carbodiimide, wherein at least a portion of the crosslink units comprise an amide bond, an ester bond or both; and the crosslinked macromolecular matrix has a weight ratio of the hyaluronic acid to the collagen of 3:1 to 7:1; wherein said hydrogel component has a hyaluronic acid concentration of 16 mg/mL to 21 mg/mL and a collagen concentration of 3 mg/mL to 6 mg/mL; and a storage modulus value of between 850 Pa and 5,000 Pa, and (ii) blending the hydrogel component with a lipoaspirate to form a lipoaspirate/hydrogel graft, wherein the lipoaspirate/hydrogel graft has a lipoaspirate:hydrogel component volume ratio of 1:1 to 5:1; and (iii) administering the lipoaspirate/hydrogel graft into a soft tissue in an area on a body of an individual, wherein the lipoaspirate/hydrogel graft improves fat graft volume retention in the soft tissue in the area on the body. 2. The method of claim 1 , wherein the soft tissue comprises a volume, wherein administering the lipoaspirate/hydrogel graft increases the volume of the soft tissue. 3. The method of claim 1 , wherein the lipoaspirate/hydrogel graft is injected intradermally or subcutaneously. 4. The method of claim 1 , wherein the hyaluronic acid has a molecular weight of about 0.25 MDa, about 0.5 MDa, about 0.75 MDa, about 1 MDa, about 1.25 MDa, about 1.5 MDa, about 1.75 MDa, about 2 MDa, about 2.25 MDa, about 2.5 MDa, about 2.75 MDa, about 3.0 MDa, about 3.25 MDa, about 3.5 MDa, about 3.75 MDa, about 4.0 MDa, about 4.25 MDa, about 4.5 MDa, about 4.75 MDa, or about 5.0 MDa. 5. The method of claim 1 , wherein the lipoaspirate is from the individual. 6. The method of claim 1 , wherein the lipoaspirate/hydrogel graft has a lipoaspirate:hydrogel component volume ratio of 1:1, 2:1, 3:1, 4:1 or 5:1. 7. The method of claim 6 , wherein the lipoaspirate/hydrogel graft has a lipoaspirate:hydrogel component volume ratio of 2:1. 8. The method of claim 6 , wherein the lipoaspirate/hydrogel graft has a lipoaspirate:hydrogel component volume ratio of 4:1. 9. The method of claim 6 , wherein the lipoaspirate/hydrogel graft has a lipoaspirate:hydrogel component volume ratio of 5:1. 10. The method of claim 1 , wherein the collagen is porcine collagen type I or human collagen type I. 11. The method of claim 1 , wherein the crosslinked macromolecular matrix has a weight ratio of the hyaluronic acid to the collagen of 4:1 to 7:1. 12. The method of claim 1 , wherein the crosslinked macromolecular matrix has a weight ratio of the hyaluronic acid to the collagen of 5:1 to 7:1. 13. The method of claim 1 , wherein the crosslinked macromolecular matrix has a weight ratio of the hyaluronic acid to the collagen of 5:1 to 6:1. 14. The method of claim 1 , wherein the lipoaspirate/hydrogel graft promotes fat graft survival.

Assignees

Inventors

Classifications

  • A61L27/52Primary

    Hydrogels or hydrocolloids · CPC title

  • Gels · CPC title

  • Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof · CPC title

  • Polysaccharides · CPC title

  • Collagen · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11844878B2 cover?
Hydrogels comprising a macromolecular matrix and water may be used to augment soft tissue of a human being, promote or support cell or tissue viability or proliferation, create space in tissue, and for other purposes. A macromolecular matrix may comprise a hyaluronic acid component crosslinked to a collagen component.
Who is the assignee on this patent?
Allergan Inc
What technology area does this patent fall under?
Primary CPC classification A61L27/52. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).